Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 5 (2008), Issue 6 (June)

1. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism.
   Phys Ther, 88(6): 733-46. [Abstract] [Full-text]
2. Enhanced frontal low and high frequency power and synchronization in the resting EEG of parkinsonian patients.
   Neuroimage, 41(3): 985-97. [Abstract] [Full-text]
3. Determinants of disability and quality of life in mild to moderate Parkinson disease.
   Neurology, 70(23): 2241-7. [Abstract] [Full-text]
4. A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease.
   Neurology, 70(23): 2233-40. [Abstract] [Full-text]
5. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays.
   Am J Hum Genet, 82(6): 1375-84. [Abstract] [Full-text]
6. Protein stability and aggregation in Parkinson's disease.
   Biochem J, 413(1): 1-13. [Abstract] [Full-text]
7. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.
   Arch Neurol, 65(6): 802-8. [Abstract] [Full-text]
8. There is no Parkinson disease.
   Arch Neurol, 65(6): 705-8. [Abstract] [Full-text]
9. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
   Arch Neurol, 65(6): 716-23. [Abstract] [Full-text]
10. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
    Neurology, 70(24): 2277-83. [Abstract] [Full-text]
11. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
    J Am Chem Soc, 130(24): 7766-73. [Abstract] [Full-text]
12. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance.
    J Neurosci, 28(24): 6165-73. [Abstract] [Full-text]
13. Will stem cell biology generate new therapies for Parkinson's disease?
    Neuron, 58(5): 659-61. [Abstract] [Full-text]
14. An expert opinion on safinamide in Parkinson's disease.
    Expert Opin Investig Drugs, 17(7): 1115-25. [Abstract] [Full-text]
15. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Exp Neurol, 212(1): 226-9. [Abstract] [Full-text]
16. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
    Hum Mol Genet, 17(13): 1988-93. [Abstract] [Full-text]
17. Protein folding diseases and neurodegeneration: lessons learned from yeast.
    Biochim Biophys Acta, 1783(7): 1381-95. [Abstract] [Full-text]
18. Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.
    Free Radic Biol Med, 45(3): 242-55. [Abstract] [Full-text]
19. Neural correlates of dual task performance in patients with Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 79(7): 760-6. [Abstract] [Full-text]
20. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 79(7): 789-95. [Abstract] [Full-text]
21. Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry, 79(7): 813-9. [Abstract] [Full-text]
22. Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation.
    Neurogastroenterol Motil, 20(7): 741-9. [Abstract] [Full-text]
23. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    J Mol Biol, 380(3): 444-50. [Abstract] [Full-text]
24. A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset.
    Neurobiol Dis, 31(1): 102-9. [Abstract] [Full-text]
25. Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease.
    Neurobiol Dis, 31(1): 41-5. [Abstract] [Full-text]
26. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Exp Biol Med (Maywood), 233(7): 881-90. [Abstract] [Full-text]
27. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort.
    Eur J Neurol, 15(7): 643-8. [Abstract] [Full-text]
28. Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease.
    Eur J Neurol, 15(7): 737-42. [Abstract] [Full-text]
29. The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease.
    Eur J Neurol, 15(7): 743-5. [Abstract] [Full-text]
30. Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study.
    Eur J Neurol, 15(7): 685-91. [Abstract] [Full-text]
31. Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.
    Eur J Neurol, 15(7): 692-6. [Abstract] [Full-text]
32. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.
    Arch Phys Med Rehabil, 89(7): 1221-9. [Abstract] [Full-text]
33. Detection of walking periods and number of steps in older adults and patients with Parkinson's disease: accuracy of a pedometer and an accelerometry-based method.
    Age Ageing, 37(4): 436-41. [Abstract] [Full-text]
34. Everyday cognitive failures and memory problems in Parkinson's patients without dementia.
    Brain Cogn, 67(3): 340-50. [Abstract] [Full-text]
35. Stimulus timing by people with Parkinson's disease.
    Brain Cogn, 67(3): 264-79. [Abstract] [Full-text]
36. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
    Hum Mol Genet, 17(14): 2160-71. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.